DrugPatentWatch Database Preview
Email this page to a colleagueSee Plans and Pricing
« Back to Dashboard
Avaclyr is a drug marketed by Fera Pharms Llc and is included in one NDA.
The generic ingredient in AVACLYR is acyclovir. There are fifty-six drug master file entries for this compound. Sixty-seven suppliers are listed for this compound. Additional details are available on the acyclovir profile page.
A generic version of AVACLYR was approved as acyclovir by DAVA PHARMS INC on April 22nd, 1997.
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Fera Pharms Llc||AVACLYR||acyclovir||OINTMENT;OPHTHALMIC||202408-001||Mar 29, 2019||DISCN||Yes||No||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|